197 related articles for article (PubMed ID: 36892668)
21. Metachronous, multicentric glioma of pilocytic astrocytoma with oligodendroglioma-like component and oligodendroglioma through distinct genetic aberrations.
Kanoke A; Kanamori M; Kumabe T; Saito R; Watanabe M; Tominaga T
J Neurosurg; 2013 Apr; 118(4):854-8. PubMed ID: 23082883
[TBL] [Abstract][Full Text] [Related]
22. Pilocytic astrocytomas in children: prognostic factors--a retrospective study of 80 cases.
Fernandez C; Figarella-Branger D; Girard N; Bouvier-Labit C; Gouvernet J; Paz Paredes A; Lena G
Neurosurgery; 2003 Sep; 53(3):544-53; discussion 554-5. PubMed ID: 12943571
[TBL] [Abstract][Full Text] [Related]
23. The differential diagnosis of pilocytic astrocytoma with atypical features and malignant glioma: an analysis of 16 cases with emphasis on distinguishing molecular features.
Cykowski MD; Allen RA; Kanaly AC; Fung KM; Marshall R; Perry A; Stolzenberg ED; Dunn ST
J Neurooncol; 2013 Dec; 115(3):477-86. PubMed ID: 24057326
[TBL] [Abstract][Full Text] [Related]
24. Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma.
Korshunov A; Meyer J; Capper D; Christians A; Remke M; Witt H; Pfister S; von Deimling A; Hartmann C
Acta Neuropathol; 2009 Sep; 118(3):401-5. PubMed ID: 19543740
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical analysis of GFAP-δ and nestin in cerebral astrocytomas.
Brehar FM; Arsene D; Brinduse LA; Gorgan MR
Brain Tumor Pathol; 2015 Apr; 32(2):90-8. PubMed ID: 25178519
[TBL] [Abstract][Full Text] [Related]
26. Cerebellar glioblastoma: a clinical series with contemporary molecular analysis.
Hong B; Banan R; Christians A; Nakamura M; Lalk M; Lehmann U; Hartmann C; Krauss JK
Acta Neurochir (Wien); 2018 Nov; 160(11):2237-2248. PubMed ID: 30203362
[TBL] [Abstract][Full Text] [Related]
27. Pilocytic astrocytoma presenting as an intrinsic brainstem tumor: case report and review of the literature.
Shaya MR; Fowler MR; Nanda A
J La State Med Soc; 2004; 156(1):33-6. PubMed ID: 15000211
[TBL] [Abstract][Full Text] [Related]
28. Proliferative Index in Pediatric Pilocytic Astrocytoma by Region of Origin and Prediction of Clinical Behavior.
Tu A; Robison A; Melamed E; Buchanan I; Hariri O; Babu H; Szymanski L; Krieger M
Pediatr Neurosurg; 2018; 53(6):395-400. PubMed ID: 30428478
[TBL] [Abstract][Full Text] [Related]
29. Biologic tumor behavior in pilocytic astrocytomas.
Belirgen M; Berrak SG; Ozdag H; Bozkurt SU; Eksioglu-Demiralp E; Ozek MM
Childs Nerv Syst; 2012 Mar; 28(3):375-89. PubMed ID: 22246337
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical study of central neurocytoma, subependymoma, and subependymal giant cell astrocytoma.
You H; Kim YI; Im SY; Suh-Kim H; Paek SH; Park SH; Kim DG; Jung HW
J Neurooncol; 2005 Aug; 74(1):1-8. PubMed ID: 16078101
[TBL] [Abstract][Full Text] [Related]
31. Predictive factors for early symptomatic recurrence in pilocytic astrocytoma: does angiogenesis have a role to play?
Kurwale NS; Suri V; Suri A; Sarkar C; Gupta DK; Sharma BS; Mahapatra AK
J Clin Neurosci; 2011 Apr; 18(4):472-7. PubMed ID: 21292490
[TBL] [Abstract][Full Text] [Related]
32. Expression profiles of 151 pediatric low-grade gliomas reveal molecular differences associated with location and histological subtype.
Bergthold G; Bandopadhayay P; Hoshida Y; Ramkissoon S; Ramkissoon L; Rich B; Maire CL; Paolella BR; Schumacher SE; Tabak B; Ferrer-Luna R; Ozek M; Sav A; Santagata S; Wen PY; Goumnerova LC; Ligon AH; Stiles C; Segal R; Golub T; Grill J; Ligon KL; Chan JA; Kieran MW; Beroukhim R
Neuro Oncol; 2015 Nov; 17(11):1486-96. PubMed ID: 25825052
[TBL] [Abstract][Full Text] [Related]
33. Pediatric low-grade gliomas can be molecularly stratified for risk.
Yang RR; Aibaidula A; Wang WW; Chan AK; Shi ZF; Zhang ZY; Chan DTM; Poon WS; Liu XZ; Li WC; Zhang RQ; Li YX; Chung NY; Chen H; Wu J; Zhou L; Li KK; Ng HK
Acta Neuropathol; 2018 Oct; 136(4):641-655. PubMed ID: 29948154
[TBL] [Abstract][Full Text] [Related]
34. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
[TBL] [Abstract][Full Text] [Related]
35. Is it a new culprit? "TERT promoter mutation" in an aggressive pediatric pilocytic astrocytoma.
Francis JV; Tanrıkulu B; Danyeli AE; Özek MM
Childs Nerv Syst; 2021 Mar; 37(3):1003-1008. PubMed ID: 32813054
[TBL] [Abstract][Full Text] [Related]
36. Low rates of recurrence and slow progression of pediatric pilocytic astrocytoma after gross-total resection: justification for reducing surveillance imaging.
Dodgshun AJ; Maixner WJ; Hansford JR; Sullivan MJ
J Neurosurg Pediatr; 2016 May; 17(5):569-72. PubMed ID: 26722760
[TBL] [Abstract][Full Text] [Related]
37. Molecular characterization of disseminated pilocytic astrocytomas.
Gessi M; Engels AC; Lambert S; Rothämel T; von Hornstein S; Collins VP; Denkhaus D; Gnekow A; Pietsch T
Neuropathol Appl Neurobiol; 2016 Apr; 42(3):273-8. PubMed ID: 26084390
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the clinical features and treatment outcomes of pilocytic astrocytoma in pediatric and adult patients.
Kim JW; Phi JH; Kim SK; Lee JH; Park SH; Won JK; Choi JY; Kang HJ; Park CK
Childs Nerv Syst; 2023 Mar; 39(3):583-591. PubMed ID: 36662276
[TBL] [Abstract][Full Text] [Related]
39. The molecular characteristics of spinal cord gliomas with or without H3 K27M mutation.
Chai RC; Zhang YW; Liu YQ; Chang YZ; Pang B; Jiang T; Jia WQ; Wang YZ
Acta Neuropathol Commun; 2020 Mar; 8(1):40. PubMed ID: 32228694
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological and immunohistochemical features of three pilomyxoid astrocytomas: comparative study with 11 pilocytic astrocytomas.
Amatya VJ; Akazawa R; Sumimoto Y; Takeshima Y; Inai K
Pathol Int; 2009 Feb; 59(2):80-5. PubMed ID: 19154260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
